Pure Global

E2 Test(Estradiol Rapid Quantitative Test) - India CDSCO Medical Device Registration

E2 Test(Estradiol Rapid Quantitative Test) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000191_69f1ba576334d901011e3c2f9347e29a_2aee097b7da964bdf4937c82407f6c92. This device is marketed under the brand name Testosterone Rapid Quantitative Test. The license holder is Matrix Labs, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
E2 Test(Estradiol Rapid Quantitative Test)
UID: IMP/IVD/2019/000191_69f1ba576334d901011e3c2f9347e29a_2aee097b7da964bdf4937c82407f6c92

Brand Name

Testosterone Rapid Quantitative Test

License Holder

Matrix Labs

Device Class

Class B

Approving Authority

CDSCO

Product Information

The FinecareTM Estradiol (Testosterone Rapid Quantitative Test) Rapid Quantitative Test is a fluorescence immunoassay used along with FinecareTM FIA Meters (Testosterone Rapid Quantitative Test) is for quantitative measurement of Estradiol (Testosterone Rapid Quantitative Test) in human whole blood, serum or plasma. The test is used as an aid to the evaluation of ovarian diseases

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing